Login / Signup

Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang.

Emanuel Della-TorreGiovanni LandoniAlberto ZangrilloLorenzo Dagna
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • mechanical ventilation
  • respiratory failure
  • coronavirus disease
  • acute respiratory distress syndrome
  • intensive care unit
  • sars cov
  • early onset
  • drug induced
  • respiratory syndrome coronavirus